Councils - Basic Science and Translational Research



Scientific Council on Basic Science & Translational Research



NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 12 Scientific Councils.



RECENT COUNCIL MEETING:
Wednesday, April 11, 2018, 7:15-8:15 AM
Room: Clio/Thalie/Erato
Location: Acropolis Congrès Centre, Nice, France
ISHLT 38th Annual Meeting and Scientific Sessions



BSTR JOURNAL WATCH:

Visit the BSTR Journal Watch page for more information.



LINKS NEWSLETTER:

Issues focusing on Basic Science:

December 2016
August 2016
June 2015: BSTR Council Year in Review
December 2014
November 2013
July 2013
May 2013: BSTR Council Year in Review
August 2012
August 2011 (PDF)




INTERESTED IN MENTORSHIP?

Visit the Junior Faculty and Trainee Council page for information on the ISHLT Mentorship Program

COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR
Edward Cantu, III, MD (2021)
Hospital of the University of Pennsylvania
Philadelphia, PA, USA

Edward Cantu, MD MSCE is the Director of Lung Transplant Research, Director of Ex Vivo Lung Perfusion and Associate Director of Lung Transplantation at the University of Pennsylvania. His laboratory is focused on acute lung injury and primary graft dysfunction after lung transplantation with emphasis on prediction, mechanism and therapeutic discovery. Dr. Cantu is currently actively funded by the NIH, Robert Wood Johnson Foundation, the STS, and the Philadelphia Antiques Show.


COUNCIL VICE CHAIR
Joshua M Diamond, MD (2023)
University of Pennsylvania
Philadelphia, PA, USA

Joshua M. Diamond, M.D., M.S.C.E is currently the Associate Medical Director of the University of Pennsylvania Lung Transplant Program in Philadelphia, PA. His research is focused on translational studies of the risks, pathogenesis, and outcomes of primary graft dysfunction (PGD) and the evaluation of potential therapies for PGD in the lung transplant population. In addition to his transplant roles, he is also the Director of the Clinical Research Track for the Penn pulmonary fellowship program.


COUNCIL PAST CHAIR
Sonja Schrepfer, MD, PhD (2019)
University of California San Francisco (UCSF)
Department of Surgery
Transplant and Stem Cell Immunobiology Lab (TSI)
San Francisco, CA, USA and
University Heart Center Hamburg
Transplant and Stem Cell Immunobiology Lab (TSI)
Hamburg, Germany

Sonja Schepfer, MD, PhD is Director of the Transplant and Stem Cell Immunobiology (TSI)-Lab at the University Heart Center in Hamburg, Germany. She is also a Visiting professor of CT Surgery at the Stanford University, School of Medicine. Her laboratory investigates experimental cardiac and lung transplantation, myocardial restoration, and vascular biology and her specific area of interest is translational research of stem cell immunobiology and solid organ transplantation.


BOARD OF DIRECTORS LIAISON
Dirk Van Raemdonck, MD, PHD (2019)
University Hospital Gasthuisberg
Leuven, BELGIUM

Dirk Van Raemdonck, MD, PHD, is a Professor of Surgery at the Katholieke Universiteit Leuven and Chair of the Leuven University Hospitals Transplant Center, Leuven, Belgium. As a General Thoracic Surgeon he currently serves as the Surgical Director of the Leuven Lung Transplant Program. He graduated as MD from the Katholieke Universiteit Leuven in 1984. He finished his training in general surgery in 1990 and in thoracic surgery in 1992. He was a registrar in thoracic surgery at the East Birmingham Hospital, Birmingham, U.K in 1990 (Prof HR Matthews), research fellow at the Memorial Sloan-Kettering Cancer Center, New York, N.Y. in 1991 (Dr RJ Ginsberg), and cardiothoracic transplant fellow at the Freeman Hospital, Newcastle-upon-Tyne, U.K. in 1991 (Prof JH Dark). He obtained his PHD degree from the Katholieke Universiteit Leuven in 1998. His main research topic is lung transplantation with particular interest in primary graft dysfunction, donation from donors after circulatory death, and ex-vivo lung perfusion.


SENIOR ADVISOR
Doris A. Taylor, PhD (2019)
University of Minnesota
Minneapolis, Minnesota, USA

Doris A. Taylor, PhD, FAHA, FACC, is Founder, President, and CEO of Stem Cell Security, a cell banking and data management company in Houston, Texas. A pioneer in cardiovascular cell therapy and regenerative medicine research, Dr. Taylor has committed her entire career to moving innovative therapies from bench to bedside. Her mechanistic insights and effective approaches to cardiac repair and replacement are well established and include a number of firsts. She holds several invention disclosures, patent applications, and patents, and is the founder of multiple companies dedicated to cardiovascular repair technologies.


SENIOR ADVISOR
Jeffrey L. Platt, MD (2019)
University of Michigan
Ann Arbor, Michigan, USA

Jeffrey L. Platt, M.D. directs the Transplantation Biology Program and serves as Professor of Surgery, and Professor of Microbiology and Immunology at the University of Michigan.  He investigates how T cells and B cells and their products interact with tissues to cause disease and to induce protection against further injury, how novel approaches might be used to replace organ function and restore immunological fitness and how fusion of one cell with another impacts on genomic integrity and cellular function. Dr. Platt is trained in Pediatrics (Childrens Hospital of LA) and nephrology (Univ Minnesota).


EDUCATION WORKFORCE LEADER
Mary Porteous, MD (2019)
Hospital of the University of Pennsylvania
Philadelphia, PA, USA

Mary Porteous, MD MSCE is currently an Assistant Professor of Medicine at the University of Pennsylvania. Her research is focused on evaluating the risks, pathogenesis, and outcomes of primary graft dysfunction after lung transplant as well as clinical progression of interstitial lung disease prior to transplantation. She earned a Master's Degree in clinical epidemiology from the University of Pennsylvania in 2015 with a thesis focused on the impact of diastolic dysfunction on primary graft dysfunction after lung transplantation.


LINKS NEWSLETTER LIAISON
Howard J. Eisen, MD, FAHA, FACC, FACP (2020)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA

Bio coming soon...

STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:
Hrishikesh Kulkarni, MD (2021)
Washington University in St. Louis
St. Louis, MO, USA

Bio coming soon...

HFTX COUNCIL LIAISON
Pradeep P.A. Mammen, MD, FACC, FAHA (2020)
UT Southwestern Medical Center
Dallas, Texas, USA


ID COUNCIL LIAISON
Aric Gregson, MD (2020)
AG Infectious Diseases
Los Angeles, CA, USA

Bio coming soon...

JUNIOR FACULTY & TRAINEE COUNCIL LIAISON
Simon Pecha, MD (2019)
University Hospital Hamburg
Hamburg, GERMANY

Simon Pecha, MD, is a Cardiac Surgeon at University Heart Center Hamburg, Germany and leads a Research group for Myocardial Tissue Engineering at Cardiovascular Research Center Hamburg. He obtained his MD from University of Tuebingen and received his training in Cardiovascular Surgery at University Heart Center Hamburg. His research is related to Cardiac Regeneration with a focus on Myocardial tissue engineering from human induced pluripotent stem cells. Dr. Pecha received several awards for his research including the Philip K. Caves Award in 2015 from the ISHLT and the Dr. Martini Price 2017 from the Dr. Martini Foundation.


MCS COUNCIL LIAISON
J. Michael DiMaio, MD (2020)
Baylor University Medical Center
Dallas, TX, USA


NHSAH COUNCIL LIAISON
Monica Horn, RN, CCRN, CCTC (2020)
Children’s Hospital Los Angeles
Los Angeles, CA, USA

Monica Horn is a Heart Transplant/VAD/PH Coordinator II, Lead at Children’s Hospital Los Angeles. Previously a pediatric critical care RN, she became a cardiothoracic transplant coordinator in 1994, working with lung/heart-lung/lobar lung transplant,  heart transplant, pulmonary hypertension and ventricular assist device patients while participating in multiple research publications regarding these populations throughout this time. Recent interests have included multidisciplinary collaboration in care of pediatric ventricular assist device patients and patients referred for heart transplantation who have had multiple previous palliative congenital heart surgeries.



PATH COUNCIL LIAISON
Annalisa Angelini, MD (2020)
University of Padua
Padova, ITALY


PH COUNCIL LIAISON
Aaron B Waxman, MD, PhD (2020)
Brigham & Women's Hospital
Boston, MA, USA

Bio coming soon...

PULM TX COUNCIL LIAISON
Pablo G. Sanchez, MD, PhD (2020)
University of Pittsburgh
Pittsburgh, PA, USA

Pablo G Sanchez, MD PhD, is a Lung Transplant Surgeon. He is the  Associate Director of Lung Transplant and the Adult ECLS program and the Director of Ex vivo Lung Perfusion and Lung Transplant Research at the University of Pittsburgh. He is a national co-investigator for the NOVEL trial, evaluating the use of ex vivo perfusion to increase lung donor use. He received the F. Griffith Pearson Fellowship from The American Association for Thoracic Surgery. He has also received funding from the Maryland Stem Cell Research Foundation, the ISHLT research fellowship award and the University of Maryland and Living Legacy Foundation Transplantation Grant Program Award.
Text SizeIncrease Font SizeDecrease Font Size